Insider Trades50 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Sell | ALEC | Grace Wong-Sarad | Principal Accounting Officer | 9,184 | $1.94 | $166.5M | -55.88% | +37.61% | $17.8K | -4.51% | 10b5-1 | Trim |
| Jun 2, 2026 | Sell | ALEC | Neil Lindsay Berkley | CFO & Chief Business Officer | 19,360 | $1.97 | $166.5M | -55.88% | +37.61% | $38.2K | -4.85% | — | Trim |
| Jun 2, 2026 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 87,216 | $1.97 | $166.5M | -55.88% | +37.61% | $172.2K | -3.55% | — | Trim |
| Apr 16, 2026 | Sell | ALEC | Grace Wong-Sarad | Principal Accounting Officer | 1,820 | $2.65 | $166.5M | -55.88% | +37.61% | $4.8K | -1.71% | 10b5-1 | Trim |
| Mar 10, 2026 | Sell | ALEC | Grace Wong-Sarad | Principal Accounting Officer | 1,000 | $2.65 | $166.5M | -55.88% | +37.61% | $2.6K | -0.93% | 10b5-1 | Trim |
| Mar 3, 2026 | Sell | ALEC | Grace Wong-Sarad | Principal Accounting Officer | 3,367 | $2.08 | $166.5M | -55.88% | +37.61% | $7.0K | -3.04% | 10b5-1 | Trim |
| Mar 2, 2026 | Sell | ALEC | Grace Wong-Sarad | Principal Accounting Officer | 8,071 | $2.12 | $166.5M | -55.88% | +37.61% | $17.1K | -6.79% | — | Trim |
| Mar 2, 2026 | Sell | ALEC | Neil Lindsay Berkley | CFO & Chief Business Officer | 29,649 | $2.12 | $166.5M | -55.88% | +37.61% | $63.0K | -7.92% | — | Trim |
| Mar 2, 2026 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 81,864 | $2.12 | $166.5M | -55.88% | +37.61% | $173.8K | -3.38% | — | Trim |
| Feb 26, 2026 | Sell | ALEC | Grace Wong-Sarad | Principal Accounting Officer | 4,079 | $2.50 | $166.5M | -55.88% | +37.61% | $10.2K | -3.32% | 10b5-1 | Trim |
| Dec 5, 2025 | Sell | ALEC | Grace Wong-Sarad | Principal Accounting Officer | 4,753 | $1.21 | $166.5M | -55.88% | +37.61% | $5.8K | -3.72% | 10b5-1 | Trim |
| Dec 3, 2025 | Sell | ALEC | Grace Wong-Sarad | Principal Accounting Officer | 8,056 | $1.12 | $166.5M | -55.88% | +37.61% | $9.0K | -5.93% | — | Trim |
| Dec 3, 2025 | Sell | ALEC | Neil Lindsay Berkley | Chief Bus Ofcr & Interim CFO | 37,261 | $1.12 | $166.5M | -55.88% | +37.61% | $41.7K | -9.05% | — | Trim |
| Dec 3, 2025 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 41,687 | $1.12 | $166.5M | -55.88% | +37.61% | $46.7K | -7.67% | — | Trim |
| Dec 3, 2025 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 104,347 | $1.12 | $166.5M | -55.88% | +37.61% | $116.8K | -4.13% | — | Trim |
| Sep 2, 2025 | Sell | ALEC | Grace Wong-Sarad | Principal Accounting Officer | 5,910 | $2.50 | $166.5M | -55.88% | +37.61% | $14.8K | -5.40% | — | Trim |
| Sep 2, 2025 | Sell | ALEC | Neil Lindsay Berkley | Principal Financial Officer | 15,842 | $2.50 | $166.5M | -55.88% | +37.61% | $39.6K | -4.37% | — | Trim |
| Sep 2, 2025 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 23,638 | $2.50 | $166.5M | -55.88% | +37.61% | $59.0K | -4.17% | — | Trim |
| Sep 2, 2025 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 51,562 | $2.50 | $166.5M | -55.88% | +37.61% | $128.7K | -2.15% | — | Trim |
| Jun 2, 2025 | Sell | ALEC | Marc Grasso | Chief Financial Officer | 16,488 | $1.34 | $166.5M | -55.88% | +37.61% | $22.1K | -5.28% | — | Trim |
| Jun 2, 2025 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 23,890 | $1.34 | $166.5M | -55.88% | +37.61% | $32.0K | -4.46% | — | Trim |
| Jun 2, 2025 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 52,087 | $1.34 | $166.5M | -55.88% | +37.61% | $69.7K | -2.11% | — | Trim |
| Mar 3, 2025 | Sell | ALEC | Gary Romano | Chief Medical Officer | 16,306 | $1.47 | $166.5M | -55.88% | +37.61% | $23.9K | -4.67% | — | Trim |
| Mar 3, 2025 | Sell | ALEC | Marc Grasso | Chief Financial Officer | 18,091 | $1.47 | $166.5M | -55.88% | +37.61% | $26.5K | -5.47% | — | Trim |
| Mar 3, 2025 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 29,073 | $1.47 | $166.5M | -55.88% | +37.61% | $42.7K | -5.14% | — | Trim |
| Mar 3, 2025 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 40,330 | $1.47 | $166.5M | -55.88% | +37.61% | $59.2K | -1.61% | — | Trim |
| Dec 2, 2024 | Sell | ALEC | Gary Romano | Chief Medical Officer | 14,892 | $2.52 | $166.5M | -55.88% | +37.61% | $37.5K | -4.09% | — | Trim |
| Dec 2, 2024 | Sell | ALEC | Marc Grasso | Chief Financial Officer | 16,489 | $2.52 | $166.5M | -55.88% | +37.61% | $41.5K | -4.75% | — | Trim |
| Dec 2, 2024 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 26,500 | $2.52 | $166.5M | -55.88% | +37.61% | $66.8K | -4.48% | — | Trim |
| Dec 2, 2024 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 52,172 | $2.52 | $166.5M | -55.88% | +37.61% | $131.4K | -2.04% | — | Trim |
| Sep 3, 2024 | Sell | ALEC | Marc Grasso | Chief Financial Officer | 7,297 | $4.88 | $166.5M | -55.88% | +37.61% | $35.6K | -5.29% | — | Trim |
| Sep 3, 2024 | Sell | ALEC | Gary Romano | Chief Medical Officer | 8,478 | $4.88 | $166.5M | -55.88% | +37.61% | $41.4K | -4.50% | — | Trim |
| Sep 3, 2024 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 13,926 | $4.88 | $166.5M | -55.88% | +37.61% | $68.0K | -4.56% | — | Trim |
| Sep 3, 2024 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 26,499 | $4.88 | $166.5M | -55.88% | +37.61% | $129.4K | -1.34% | — | Trim |
| Jun 3, 2024 | Sell | ALEC | Marc Grasso | Chief Financial Officer | 6,920 | $4.80 | $166.5M | -55.88% | +37.61% | $33.2K | -4.77% | — | Trim |
| Jun 3, 2024 | Sell | ALEC | Gary Romano | Chief Medical Officer | 8,040 | $4.80 | $166.5M | -55.88% | +37.61% | $38.6K | -4.10% | — | Trim |
| Jun 3, 2024 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 13,206 | $4.80 | $166.5M | -55.88% | +37.61% | $63.4K | -4.14% | — | Trim |
| Jun 3, 2024 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 25,135 | $4.80 | $166.5M | -55.88% | +37.61% | $120.6K | -1.26% | — | Trim |
| Mar 4, 2024 | Sell | ALEC | Marc Grasso | Chief Financial Officer | 5,716 | $6.92 | $166.5M | -55.88% | +37.61% | $39.6K | -3.79% | — | Trim |
| Mar 4, 2024 | Sell | ALEC | Gary Romano | Chief Medical Officer | 6,001 | $6.92 | $166.5M | -55.88% | +37.61% | $41.6K | -2.97% | — | Trim |
| Mar 4, 2024 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 10,169 | $6.92 | $166.5M | -55.88% | +37.61% | $70.4K | -3.09% | — | Trim |
| Mar 4, 2024 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 18,837 | $6.92 | $166.5M | -55.88% | +37.61% | $130.4K | -0.93% | — | Trim |
| Dec 4, 2023 | Sell | ALEC | Marc Grasso | Chief Financial Officer | 4,574 | $5.56 | $166.5M | -55.88% | +37.61% | $25.4K | -2.95% | — | Trim |
| Dec 4, 2023 | Sell | ALEC | Gary Romano | Chief Medical Officer | 5,035 | $5.56 | $166.5M | -55.88% | +37.61% | $28.0K | -2.43% | — | Trim |
| Dec 4, 2023 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 12,519 | $5.56 | $166.5M | -55.88% | +37.61% | $69.6K | -3.67% | — | Trim |
| Dec 4, 2023 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 23,831 | $5.56 | $166.5M | -55.88% | +37.61% | $132.5K | -1.17% | — | Trim |
| Sep 5, 2023 | Sell | ALEC | Marc Grasso | Chief Financial Officer | 1,114 | $5.19 | $166.5M | -55.88% | +37.61% | $5.8K | -3.34% | — | Trim |
| Sep 5, 2023 | Sell | ALEC | Gary Romano | Chief Medical Officer | 2,771 | $5.19 | $166.5M | -55.88% | +37.61% | $14.4K | -2.71% | — | Trim |
| Sep 5, 2023 | Sell | ALEC | Arnon Rosenthal | Chief Executive Officer | 5,647 | $5.19 | $166.5M | -55.88% | +37.61% | $29.3K | -0.34% | — | Trim |
| Sep 5, 2023 | Sell | ALEC | Sara Kenkare-Mitra | President and Head of R&D | 6,214 | $5.19 | $166.5M | -55.88% | +37.61% | $32.3K | -3.37% | — | Trim |